British American Tobacco Releases 2018 Harm Reduction Focus Report
Harm reduction has been a major initiative and focus of British American Tobacco (BAT) in recent years and 2018 was no different. With the...
FDA Authorizes IQOS to be Marketed as Modified Risk Tobacco Product
The U.S. Food and Drug Administration (FDA) has given Altria Group the ok to market its heat not burn device, IQOS, as a modified...
FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN
22nd Century Group, Inc., a leading agricultural biotechnology company that is focused on tobacco harm reduction and reduced nicotine tobacco products, has announced that...
Philip Morris International’s Revenue and Stock Jumps Due to IQOS
Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates.
Earlier this year, the U.S....
Altria Invests More in Reduced Harm Tobacco Product Category
Altria has long been known for its traditional cigarette products but the company's new focus could make it a leader in the reduced harm...
Is the FDA on the Brink of True Harm Reduction?
In July, the FDA announced a new regulatory plan to focus on reducing nicotine levels in cigarettes, with the purpose of reducing cigarette addiction....
